Getinge (OTCMKTS:GNGBY) Downgraded to “Hold” Rating by Zacks Research

Getinge (OTCMKTS:GNGBY) was downgraded by equities research analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a report issued on Thursday, Zacks reports.

Several other equities research analysts have also recently weighed in on the company. UBS Group initiated coverage on Getinge in a report on Wednesday, September 2nd. They issued a “hold” rating for the company. Nordea Equity Research cut Getinge from a “buy” rating to a “hold” rating in a research note on Monday, August 31st. Three research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has an average rating of “Hold”.

Getinge Stock Performance

Shares of OTCMKTS:GNGBY opened at $23.93 on Thursday. The company has a current ratio of 1.31, a quick ratio of 0.74 and a debt-to-equity ratio of 0.26. The company has a 50-day moving average price of $24.58 and a 200-day moving average price of $21.93. The company has a market cap of $6.52 billion, a price-to-earnings ratio of 22.79 and a beta of 0.93. Getinge has a 12 month low of $18.99 and a 12 month high of $25.98.

Getinge (OTCMKTS:GNGBY) last posted its earnings results on Friday, July 17th. The company reported $0.38 earnings per share (EPS) for the quarter. Getinge had a return on equity of 11.12% and a net margin of 7.81%.The company had revenue of $894.87 million for the quarter. As a group, equities analysts anticipate that Getinge will post 1.38 EPS for the current year.

Getinge Company Profile

Getinge AB is a Sweden-based medical technology company that develops products and solutions for hospitals, healthcare providers and life science organizations. Founded in 1904 in Getinge, Sweden, the company serves customers through operations and sales channels across Europe, North America, Asia-Pacific and other international markets.

Getinge organizes its business around Acute Care Therapies, Life Science and Surgical Workflows. Its offerings include ventilators, anesthesia systems, patient monitoring and cardiovascular support technologies, as well as equipment used in intensive care and other acute-care settings.